The Law Office of Abe Shainberg is investigating the Board of Directors of Martek Biosciences Corporation (NasdaqGS: MATK) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Royal DSM N.V. (NYSE: DSM). Under the terms of the transaction, Martek stockholders will receive $31.50 in cash per share for a total transaction value of approximately $1.09 billion.

The investigation concerns whether the Martek Board of Directors breached their fiduciary duties to Martek stockholders by failing to adequately shop the Company before entering into this transaction and whether Royal DSM is underpaying for Martek shares.

If you own common stock in Martek and wish to obtain additional information, please contact Abe Shainberg, Esq. either via email at as@ashainberglaw.com or by telephone at (212) 425-7286, or visit http://www.ashainberglaw.com/martek-biosciences.html.

Mr. Shainberg has expertise in prosecuting investor securities litigation, is a certified and registered arbitrator and mediator involving financial matters, and represents investors in various matters nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.

Grafico Azioni Martek (NASDAQ:MATK)
Storico
Da Gen 2025 a Feb 2025 Clicca qui per i Grafici di Martek
Grafico Azioni Martek (NASDAQ:MATK)
Storico
Da Feb 2024 a Feb 2025 Clicca qui per i Grafici di Martek